November 15, 2012
Pennsylvania joins 37 other states in $90 million settlement with GlaxoSmithKline
HARRISBURG ? Attorney General Linda Kelly today announced that Pennsylvania will receive more than $4 million as part of a national settlement with GlaxoSmithKline that resolves allegations that the company unlawfully promoted its diabetes drug, Avandia.
Kelly said that GlaxoSmithKline, a British based pharmaceutical company that operates worldwide, has agreed to pay $90 million to resolve allegations that the company engaged in unfair and deceptive practices by misrepresenting Avandia?s cardiovascular risks and safety profile.
As part of the Consent Judgment, GlaxoSmithKline agrees to reform how it markets and promotes diabetes drugs and agrees to not:
The agreement also has the following terms that are effective for at least eight years:
The investigation was led by the Attorneys General of Oregon and Illinois with an Executive Committee consisting of the Attorneys General of Arizona, Florida, Maryland, Pennsylvania, Tennessee, and Texas. Also participating in the settlement are Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Idaho, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Jersey, North Carolina, North Dakota, Ohio, Oklahoma, Rhode Island, South Dakota, Vermont, Washington, Wisconsin.
# # #